TOPIRAMATE (TOPIRAMATE) — FDA Approval ANDA210278 (GLENMARK PHARMS LTD)
TOPIRAMATE (TOPIRAMATE) — FDA Approval ANDA210278 (GLENMARK PHARMS LTD) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: TOPIRAMATE; Active ingredients: TOPIRAMATE; Application number: ANDA210278.
| Brand name | TOPIRAMATE |
|---|---|
| Active ingredients | TOPIRAMATE |
| Application number | ANDA210278 |
| Sponsor | GLENMARK PHARMS LTD |
| Dosage form | CAPSULE, EXTENDED RELEASE |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 5 |
| First approval date | 20210201 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →